AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am an Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
featured image

Netherlands FDI Alert: Consultation Launched on New Categories of (Highly) Sensitive Technologies

1 minute Jan 28 2025

Read More
Pills lined up on blue background

First decision on the SPC manufacturing waiver by the Belgian courts

Jan 28 2025

Read More
cameras

Connected - January 2025

Jan 27 2025

Read More